Factors influencing recombinant adeno-associated virus production

Human Gene Therapy

Volumn 9, Issue 5, 1998, Pages 695-706

  Salvetti, Anna ^a   Grève, Soizic ^a   Chadeuf, Gilliane ^a   Favre, David ^a   Cherel, Yan ^b   Champion Arnaud, Patrick ^a   David Ameline, Jacques ^a   Moullier, Philippe ^a  

^a HÔTEL DIEU   (France)

^b INRA UMR 703   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM CHLORIDE;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL LYSATE; CONTAMINATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; VIRUS ASSEMBLY; VIRUS PARTICLE; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; DNA VIRUSES;

EID: 0032549488     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.5-695     Document Type: Article

References (13)

1. ALLEN, J.M., DEBELAK, D.J., REYNOLDS, T.C., and MILLER, A.D. (1997). Identification and elimination of replication-competent Adeno-Associated Virus (AAV) that can arise by non homologous recombination during AAV vector production. J. Virol. 71, 6816-6822.
2. BOHL, D., SALVETTI, A., MOULLIER, P., and HEARD, J.M. (1998). Control of erythropoietrin secretion by doxycycline after AAV vector-mediated gene transfer into mouse muscle (submitted).
3. CARTER, B.J. (1990). The growth cycle of adeno-associated virus. In Handbook of Parvoviruses. P. Tjissen, eds. (CRC Press, Boca Raton, FL) pp. 155-168.
4. CARTER, B.J., LAUGHLIN, C.A., DE LA MAZA, L.M., and MYERS, M. (1979). Adeno-associated virus autointerference. Virology 92, 449.
5. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
6. CLARK, K.R., VOULGAROPOULOU, F., and JOHNSON, P.R. (1996). A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3, 1124-1132.
7. COUFFINHAL, T., KEARNEY, M., SULLIVAN, A., SILVER, M., TSURUMI, Y., and ISNER, J.M. (1997). Histochemical staining following LacZ gene transfer underestimates transfection efficiency. Hum. Gene Ther. 8, 929-934.
8. FERRARI, F.K., XIAO, X., MCCARTHY, D., and SAMULSKI, R.J. (1997). New developments in the generation of Ad-free, high-liter rAAV gene therapy vectors. Nature Med. 3, 1295-1297.
9. LAUGHLIN, C.A., MYERS, M.W., RISIN, D.L., and CARTER, B.J. (1979). Defective-interfering particles of the human parvovirus adeno-associated virus. Virology 94, 162.
10. LEONARD, C.J., and BERNS, K.I. (1994). Adeno-associated virus type 2: A latent life cycle. Prog. Nucleic Acid Res. Mol. Biol. 48, 29-53.
11. LI, J., SAMULSKI, R.J., and XIAO, X. (1997). Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236-5243.
12. MCLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988). Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62, 1963-1973.
13. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.